论文部分内容阅读
目的总结原发性肝癌切除术后复发行肝移植治疗的经验。方法2002年8月至2004年11月上海交通大学医学院附属瑞金医院对4例肝癌切除术后复发病例(其中1例合并急性肝功能衰竭)行同种异体肝移植治疗。结果3例移植术后已分别无瘤存活17个月、12个月和27个月至今。1例术后第3天死于多器官功能衰竭。结论对原发性肝癌切除术后复发病例的肝移植治疗,小肝癌切除后复发肿瘤仍符合Milan标准者有着良好的预后;个别合并门静脉癌栓者预后较好;合并急性肝功能衰竭者应相当谨慎。
Objective To summarize the experience of recurrent liver transplantation after resection of primary liver cancer. Methods From August 2002 to November 2004, 4 cases of liver cancer recurrence after liver resection (including 1 case of acute liver failure) underwent allograft transplantation in Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine. Results Three cases had no tumor-surviving for 17 months, 12 months and 27 months respectively after transplantation. One patient died of multiple organ failure on the third postoperative day. Conclusions The prognosis of patients with recurrent hepatocellular carcinoma after resection of liver transplantation and recurrence of small hepatocellular carcinoma is still in line with the standards of Milan have a good prognosis; individual with good prognosis of portal vein tumor thrombus; patients with acute liver failure should be equivalent cautious.